Long COVID Patterns in the RECOVER-Adult Study
November 21, 2025
Brand Name :
Pergonal, Humegon, Menopur, and Repronex
Synonyms :
Menotrophin, human menopausal gonadotropin, and menotropina
Class :
Protein based therapy
Dosage Forms & StrengthsÂ
Powder for injection
75 IU
150 IU
75 IU SC Once daily for 12 days
Assisted Reproductive Technology (ART)Â
225 IU IM/SC once daily
Do not exceed 450 IU once daily
150 IU IM/SC once daily in the first five days of treatment for 7-12 days
Do not exceed 450 IU once daily
Safety and efficacy is not studiedÂ
Refer to adult dosingÂ
Actions and spectrum:Â
The drug stimulates FSH and increase ovulation if there is no sufficient luteinizing hormone (LH) helps in growth and development of ovarian follicles and also in production of gonadal steroids.
Frequency definedÂ
>10%Â
Pain in the abdomen (18%)
Headache (34%)
1-10%Â
Hot flashes (0.2-2.6%)
Tender breasts (1.8%)
Migraine (2.4%)
Ovarian disease (3.8%)
Back pain (3.2%)
Malaise (2.4%)
Black Box WarningÂ
There is no specific warnings given for this drug.
Contraindication/Caution:Â
Pregnant, hypersensitive, torsion of the ovaries, and closely monitoring serum levels of testosterone.
Pregnancy Warnings:Â
Pregnancy category: X
Lactation:Â
Excretion of the drug into human breast milk is unknownÂ
Pregnancy Categories:Â
Category A: Satisfactory and well-controlled studies show no evidence of risk to the fetus in the first trimester or in the later trimester.Â
Category B: No evidence of risk to fetus found in animal reproduction studies and there are not enough studies on pregnant women.Â
Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for an effect in humans, care must be taken for potential risks in pregnant women.Â
Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms, but despite potential risks may be used only in emergency cases for potential benefits.Â
Category X: Drugs listed in this category clearly outweigh risks over benefits. These category drugs should be prohibited for pregnant women.Â
Category N: There is no data available for the drug under this category.Â
Pharmacology:Â
Menotrophin is a protein-based therapy that combines human LH and FSH.Â
Pharmacodynamics:Â
Menotropins treat female infertility by causing the pre-ovulatory ovarian follicle to rupture and stimulating late follicular maturation which helps in restarting oocyte meiosis.
Pharmacokinetics:Â
AbsorptionÂ
Absorbed rapidlyÂ
Elimination and excretionÂ
8% of the unchanged drug is excreted through urine
Half-life:
Initial phase:
LH- 20min
FSH- 4hours
Final Phase:
LH- 4 hours
FSH- 70hours
Administration:Â
Reconstitute the vial with 1 to 2 ml of NS. The reconstituted medicine should be administered immediately intramuscularly or subcutaneously as advised by the doctor.Â
Patient information leafletÂ
Generic Name: menotrophin injection
Pronounced: Mae-no-tro-fin
Why do we use menotrophin injection?Â
Menotrophin helps in ovulation and support in vitro fertilization. A combination of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) involve in the development of the follicles or eggs generate ovaries.Â